Welcome to LookChem.com Sign In|Join Free

CAS

  • or

69048-98-2

Post Buying Request

69048-98-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

69048-98-2 Usage

Chemical Properties

BEIGE-BROWNISH CRYSTALS OR POWDER

Uses

Intermediate for the synthesis of Alfentanil

Check Digit Verification of cas no

The CAS Registry Mumber 69048-98-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,0,4 and 8 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 69048-98:
(7*6)+(6*9)+(5*0)+(4*4)+(3*8)+(2*9)+(1*8)=162
162 % 10 = 2
So 69048-98-2 is a valid CAS Registry Number.
InChI:InChI=1/C3H6N4O/c1-2-7-3(8)4-5-6-7/h2H2,1H3,(H,4,6,8)

69048-98-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-ethyl-2H-tetrazol-5-one

1.2 Other means of identification

Product number -
Other names EINECS 273-844-2

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:69048-98-2 SDS

69048-98-2Relevant articles and documents

TETRAZOLONE SUBSTITUTED STEROIDS AND USE THEREOF

-

Paragraph 458-460, (2020/07/31)

The present disclosure relates to compounds of formula (AI), (I), (AII), and (II), or a pharmaceutically acceptable salt, solvate, stereoisomer, or tautomer thereof, a pharmaceutical composition comprising a compound of formula (AI), (I), (AII), and (II), and use thereof, wherein R2, R3, R4, R5, R6, R7, R10, R11a, R11b, R12, R16, R19a, R19b, and R20 are described herein. Such compounds are envisioned useful for the prevention and treatment of a variety of CNS-related conditions, for example, treatment of sleep disorders, mood disorders, movement disorders, convulsive disorders, schizophrenin spectrum disorders, disorders of memory and/or cognition, personality disorders, autism spectrum disorders, pain, traumatic brain injury, vascular diseases, substance abuse disorders and/or withdrawal syndromes, or tinnitus etc.

Tetrazolones as a Carboxylic Acid Bioisosteres

-

Paragraph 0419; 0420; 0421; 0422, (2016/08/17)

The present disclosure provides compounds that include a tetrazolone derivative of a carboxyl group of an active agent. This disclosure also relates to pharmaceutical compositions that include these compounds, methods of using these compounds in the treatment of various diseases and disorders, and processes for preparing these compounds.

SUBSTITUTED 4-AMINO-PIPERIDINES

-

Page/Page column 30-31, (2010/02/17)

The present invention relates to new substituted 4-amino-piperidine opioid receptor modulators, pharmaceutical compositions thereof, and methods of use thereof

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 69048-98-2